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 Evaluating Experimental 
 Policymaking: Lessons from 
 China’s Rural Health Reforms
Academic and policy communities are becoming 
increasingly interested in how the Chinese 
government uses experimentation in developing 
policy. Analysts of China’s experimental policy-
making frequently claim that: 
•	many reforms start with small-scale policy 
experiments before proceeding to national 
roll-out
•	 experimentation helps avoid major policy 
mistakes by allowing government to trial 
controversial measures or develop workable 
policy solutions in a restricted jurisdiction, 
minimising risk if the experiment fails 
•	 experimentation is a core component of China’s 
incremental approach to reform, and helps 
maintain resilience of the health system 
under reform.
However, there have been few detailed analyses 
of the effectiveness of such experimental 
approaches to reform, especially in the area of 
social and health services, where developing 
country governments face the challenge of 
reforming and/or building complex and inter-
dependent systems. China is currently reforming 
its rural health system after many years of neglect 
and the collapse of key components such as the 
rural health insurance system. Does China’s 
experimental approach provide lessons for other 
developing countries?
Case study: the New Cooperative 
Medical Scheme
During the planned economy period (1949–1978), 
China developed a health insurance system, the 
Cooperative Medical Scheme (CMS), which essen-
tially covered the country’s vast rural population 
and provided low-cost access to basic services and 
medicines. The CMS was run by villages or 
communes, but collapsed in most places following 
the economic reforms that began in the late 1970s. 
This left rural residents having to pay for treatment 
and medicines, frequently resulting in impoverish-
ment and/or forgoing of necessary treatment. 
Staged reform of the rural health system
Faced with the difficulty of simultaneously 
reforming multiple components of the health 
system, one of the starting points chosen by 
government for reforms in the 2000s was the 
development of a new rural health insurance 
scheme, the New Cooperative Medical Scheme 
(NCMS), which was intended to cover the whole 
rural population with low-level health insurance 
by 2010. 
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In recent years, much attention has been paid to the Chinese government’s 
experimental approach to developing policy, but few detailed evaluations of the 
effectiveness of the approach exist. The development of a rural health insurance 
system in China provides a test case to examine how experimental policy 
development can work in social and health policy. Faced with the need for 
multiple simultaneous reforms, which interact in complex ways, policy 
experimentation may be a way to ‘implement the un-implementable’ – even in 
contexts of low and varying implementation capacity. But it must be managed 
well, and consideration must be given to feedback, policy coordination, and 
capacity development.
Reforms to other parts of the rural health 
system – such as the management of medical 
facilities, drug procurement, establishment of 
monitoring and evaluation (M&E) systems, etc 
– came after the launch of the health insurance 
scheme. Crucially, in the early 2000s, medical 
facilities existed in rural areas throughout 
China (though many were in a poor state), 
providing a basis for the development of a 
functioning rural health system. A number of 
programmes have focused on strengthening 
capacity in rural hospitals and clinics.
While the development of the NCMS took 
into account some of the main lessons from 
small-scale experiments by academics and 
international agencies in the 1980s and 1990s, 
between 2003 and 2008, it was primarily 
developed through an experimental policy 
process.
Using pilots and experimental policy design
As with many Chinese policies, central govern-
ment set the parameters within which 
sub-national governments should work. Pilots 
were carried out in approximately 300 counties 
between 2003 and 2005. Many key elements 
of scheme design were left to local govern-
ments, including amounts of funding, insur-
ance coverage and design of reimburse-
ment plans, and the management of funding 
and services. Expert teams were convened to 
help guide county-level pilots, develop training 
materials on NCMS design, and carry out 
training for local government officials and 
NCMS managers. In 2006, a large-scale interim 
evaluation of the scheme was carried out. This 
helped inform subsequent policy and promote 
convergence in policy design. 
This method of policy development was 
intended to: 
•	 allow local governments to adapt the scheme 
to local conditions
•	 produce lessons that could contribute to scheme 
design and promote bottom-up learning in 
development of a central government policy.
Challenges in this method of policy develop-
ment include:
•	 very limited (and variable) capacity in county 
health administrat ions tasked with 
implementing the NCMS 
•	 lack of local-level data on burden of disease 
and health service utilisation
•	 reliance on a huge number of implementing 
units (initially around 300 counties, increasing 
to around 3,000), making coordination difficult.
Expansion of overall health reforms
By 2008, all counties had established NCMS 
pilots, though development of the scheme is 
continuing, especially following the substantial 
expansion in the scope of China’s overall health 
reforms, which started in 2009. Following the 
initial decentralised development of the NCMS, 
however, integration is now taking place: 
sub-national schemes are being enlarged to 
cover larger populations and spread risk; 
reimbursement across provincial schemes 
(which was previously not possible) is being 
piloted; and more attention is being paid to 
cost-effectiveness and provider performance. 
Since 2009, provider payment reform has been 
a focus of NCMS development, while the 
scheme itself – which covers rural residents only 
– is being integrated with urban health insur-
ance and commercial schemes.
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“While the 
development of 
the NCMS took 
into account 
some of the 
main lessons 
from earlier 
small-scale 
experiments, 
between 2003 
and 2008, it 
was primarily 
developed 
through an 
experimental 
policy process.”
Family outside a village pharmacy/clinic in Hu Kou, Shanxi Province.
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“Policy 
experimentation 
can be used to 
develop solutions 
to specific 
policy problems, 
but it should 
not be a 
substitute for 
policy design.”
Emerging lessons on experimental 
policy development
Limited and varying sub-national capacity 
need not be a barrier to developing 
functioning systems
Before 2003 and the launch of the NCMS in 
China, most county governments had no 
experience of implementing a health insurance 
programme and no training in health economics 
or analytical methods needed for design of 
benefit packages. Following basic needs analysis 
and limited inputs of technical assistance, pilot 
counties were able to learn by trial and error, 
adjusting benefit packages and scheme design 
over time. Non-pilot counties were able to 
learn from the experience of the pilot counties 
when designing and refining their local 
schemes.
Capable and motivated local government is 
important for effective implementation
Initially, pilot counties were chosen based on 
capability and commitment to the pilot. Central 
funding for the scheme, while limited, sent a 
message to local governments that the central 
government fully backed the reform. 
National policies must be designed to allow 
flexible local management
The starting point of each pilot county varied 
in terms of its institutions and facilities, levels 
of capacity, disease profiles, costs, etc. Design 
of the NCMS allowed local flexibility under a 
unified central policy mandate. This made local 
health administrators responsible for tailoring 
the scheme to reflect local needs – for 
example, by adjusting reimbursement rates to 
encourage patients to seek treatment in 
cheaper, local clinics rather than expensive city 
hospitals.
Where starting points and institutional 
capacity vary, managing convergence in policy 
design is important
Flexible county-level implementation can 
lead to a variety of outcomes. The health 
administration at provincial and national levels 
has an important role to play in evaluating 
counties’ practices and guiding convergence in 
policy design through evaluation, training 
and developing standardised policy 
recommendations. During the piloting of the 
NCMS (2003–2005), few national policies were 
issued; most central government policy on 
NCMS development was issued between 
2006 and 2009, when the scheme was being 
rolled out and consolidated.
Experimental policy development is not a 
cure-all; sufficient attention must be paid to 
referencing existing best practice, the capacity 
of those responsible for implementation, and 
how the policy is likely to function in context
Policy experimentation can be used to develop 
solutions to specific policy problems, but it 
should not be a substitute for policy design: many 
elements of policy can (and should) be designed 
in advance, referencing international best 
practice where relevant. It is important that 
experimental policy design does not become a 
fig leaf for reducing the responsibility of central 
government and shifting the task of policy 
development to under-resourced local govern-
ments, which have limited capacity.
Baby held by his grandmother being examined by a doctor at a local clinic in 
Kunming city, Yunnan Province.
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Policy implications
•	 Effective national systems can be developed through local pilots 
The NCMS shows that it is possible to develop a complex national social 
insurance policy by substantially relying on local government trial and error with 
limited technical inputs, even where capacity is limited and uneven.
•	 Experimentation can help ‘implement the un-implementable’ 
Policy experimentation may be a useful approach for ‘implementing the 
un-implementable’, when faced with the need for multiple simultaneous 
reforms that are likely to interact in complex and unpredictable ways.
•	 Experimentation can achieve faster results 
‘Quick and dirty’ experimental piloting and subsequent standardisation may 
ultimately be faster than designing policy in advance, especially where policy 
must be implemented across a huge number of jurisdictions, where capacity for 
prior technical assistance is limited, and where delaying reform could have 
significant human consequences (for example, in missed treatments and/or 
increased impoverishment).
•	 Experimentation should not be a substitute for proper planning 
Experimental policy development should not be a substitute for sufficient 
planning and design, and referencing of existing best practice. Central 
government should provide resources and training to develop the capacity of 
those responsible for implementation.
The starting point for any policy develop-
ment process, and the remit of experi-
menters, will have a large impact on the 
resulting policy design. Sufficient atten-
tion must be paid to what the policy is 
expected to accomplish and how it will 
interact with other institutions, such as 
other components of the health system. 
The development of the NCMS largely 
ignored cost control and provider 
payment mechanisms, resulting in escala-
tion of costs; to date, the NCMS has been 
piloted and rolled out across approxi-
mately 3,000 counties, covering around 
805 million people, but evaluations 
have shown that the impact on users’ 
health spending and impoverishment has 
been limited.
